Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma, Hepatocellular × Drug Therapy × Clear all

Phase

Phase 2/3 2 Phase 2 2 Phase NA 1 Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 21 Breast Neoplasms 17 Colorectal Neoplasms 13 Ovarian Neoplasms 11 Lung Neoplasms 10 Neoplasm Metastasis 9 Stomach Neoplasms 8 Nasopharyngeal Carcinoma 8 Neoplasms 7 Leukemia, Myeloid, Acute 7 Squamous Cell Carcinoma of Head and Neck 6 Rectal Neoplasms 6 Recurrence 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Fallopian Tube Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 4 Leukemia 4 Head and Neck Neoplasms 4 Esophageal Neoplasms 4 Pancreatic Neoplasms 3 Neoplasms by Site 3 Lymphoma, Non-Hodgkin 3 Carcinoma, Ovarian Epithelial 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Multiple Myeloma 2 Melanoma 2

Interventions

Sorafenib 39 lenvatinib 19 Fluorouracil 14 Oxaliplatin 13 atezolizumab 12 Doxorubicin 12 Bevacizumab 11 Ethiodized Oil 10 Radiosurgery 9 Radiofrequency Ablation 9 Leucovorin 9 Folfox protocol 7 pembrolizumab 6 Epirubicin 6 Cisplatin 6 sintilimab 5 durvalumab 5 Radiotherapy 5 Gemcitabine 5 tremelimumab 4 apatinib 4 Nivolumab 4 Embolization, Therapeutic 4 camrelizumab 3 Tenofovir 3 Pharmaceutical Preparations 3 Mitomycin 3 Hepatectomy 3 Dexamethasone 3 Chemotherapy, Adjuvant 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07027436 2025-06-18

DARTS

Hamilton Health Sciences Corporation

Phase 3 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡